Habitual physical activity modulates cardiometabolic health in long-term testicular cancer survivors.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
26 Aug 2023
Historique:
received: 18 01 2023
accepted: 15 08 2023
medline: 28 8 2023
pubmed: 27 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

Physical activity (PA) may mitigate late cardiometabolic toxicity of cisplatin-based chemotherapy in testicular germ cell tumor (TGCT) long-term survivors. In this cross-sectional study, we evaluated the effects of habitual PA on metabolic syndrome (MetS) prevalence, and on the markers of cardiometabolic health and chronic inflammation in a population of long-term TGCT survivors. MetS prevalence was evaluated, and habitual PA was assessed using Baecke's habitual PA questionnaire in TGCT survivors (n=195, age=41.1±8.1years, 11.7±5.2years post-therapy) and healthy male controls (n=41, age=38.2±8.8years). Participants were stratified into low- and high-PA groups based on median values. Differences were examined between low- and high-PA groups (in the entire sample, TGCT survivor sub-samples differing in disease stage, and healthy controls), and between TGCT survivors and controls. Next, TGCT survivors were stratified into age- and BMI-matched sub-groups based on post-treatment time (5-15/15/30years) and number of chemotherapy cycles (≤3/>3), allowing us to detect age- and BMI-independent effects of habitual PA on cardiometabolic health in the given TGCT survivor sub-populations. A correlation matrix of habitual PA and sport activity with cardiometabolic and pro-inflammatory markers was generated. TGCT survivors had higher MetS prevalence than controls. Patients with high habitual PA had lower waist circumference and Systemic Inflammation Index. Habitual PA scores correlated positively with HDL-cholesterol and negatively with waist circumference and atherogenic risk. Furthermore, cardiometabolic benefits of habitual PA were more pronounced in patients with disease stages 1 and 2. Effects of habitual PA on patients sub-populations stratified by chemotherapy dose and post-treatment time clearly showed that higher levels of habitual PA were associated with lower numbers of MetS components, except for patients who received more than 3 chemotherapy cycles and were examined more than15 years post-therapy. Higher levels of habitual PA effectively mitigated cardiometabolic toxicity in TGCT survivors. Patients with higher cumulative doses of chemotherapy may need structured exercise interventions involving higher-intensity physical activity to achieve significant improvements in cardiometabolic health.

Identifiants

pubmed: 37632597
doi: 10.1007/s00520-023-08000-1
pii: 10.1007/s00520-023-08000-1
pmc: PMC10460370
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

539

Informations de copyright

© 2023. The Author(s).

Références

Hanna NH, Einhorn LH (2014) Testicular cancer--discoveries and updates. N Engl J Med 371(21):2005–2016
pubmed: 25409373 doi: 10.1056/NEJMra1407550
Singh R, Fazal Z, Freemantle SJ, Spinella MJ (2019) Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors. Cancer Drug Resist 2(3):580–594
pubmed: 31538140 pmcid: 6752046
Sprauten M, Haugnes HS, Brydoy M, Kiserud C, Tandstad T, Bjoro T et al (2015) Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors. Ann Oncol 26(10):2133–2140
pubmed: 26265167 doi: 10.1093/annonc/mdv328
Efstathiou E, Logothetis CJ (2006) Review of late complications of treatment and late relapse in testicular cancer. J Natl Compr Cancer Netw 4(10):1059–1070
doi: 10.6004/jnccn.2006.0088
Haugnes HS, Bosl GJ, Boer H, Gietema JA, Brydoy M, Oldenburg J et al (2012) Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up. J Clin Oncol 30(30):3752–3763
pubmed: 23008318 doi: 10.1200/JCO.2012.43.4431
Chovanec M, Vasilkova L, Setteyova L, Obertova J, Palacka P, Rejlekova K et al (2018) Long-term cognitive functioning in testicular germ-cell tumor survivors. Oncologist 23(5):617
pubmed: 29352051 pmcid: 5947452 doi: 10.1634/theoncologist.2017-0457
Kerns SL, Fung C, Monahan PO, Ardeshir-Rouhani-Fard S, Abu Zaid MI, Williams AM et al (2018) Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: a multi-institutional study. J Clin Oncol 36(15):1505–1512
pubmed: 29617189 pmcid: 5959198 doi: 10.1200/JCO.2017.77.0735
Huddart RA, Norman A, Shahidi M, Horwich A, Coward D, Nicholls J et al (2003) Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 21(8):1513–1523
pubmed: 12697875 doi: 10.1200/JCO.2003.04.173
Amiri A, Chovanec M, Oliva V, Sedliak M, Mego M, Ukropec J et al (2021) Chemotherapy-induced toxicity in patients with testicular germ cell tumors: the impact of physical fitness and regular exercise. Andrology 9:1879–1892
pubmed: 34245663 doi: 10.1111/andr.13078
Yang R, Chang Q, Meng X, Gao N, Wang W (2018) Prognostic value of systemic immune-inflammation index in cancer: a meta-analysis. J Cancer 9(18):3295–3302
pubmed: 30271489 pmcid: 6160683 doi: 10.7150/jca.25691
Chovanec M, Cierna Z, Miskovska V, Machalekova K, Kalavska K, Rejlekova K et al (2018) Systemic immune-inflammation index in germ-cell tumours. Br J Cancer 118(6):831–838
pubmed: 29485980 pmcid: 5877428 doi: 10.1038/bjc.2017.460
Segal R, Zwaal C, Green E, Tomasone JR, Loblaw A, Petrella T et al (2017) Exercise for people with cancer: a systematic review. Curr Oncol 24(4):e290–e315
pubmed: 28874900 pmcid: 5576469 doi: 10.3747/co.24.3619
Fuller JT, Hartland MC, Maloney LT, Davison K (2018) Therapeutic effects of aerobic and resistance exercises for cancer survivors: a systematic review of meta-analyses of clinical trials. Br J Sports Med 52(20):1311
pubmed: 29549149 doi: 10.1136/bjsports-2017-098285
Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL et al (2012) Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 62(4):243–274
pubmed: 22539238 doi: 10.3322/caac.21142
Segal R, Zwaal C, Green E, Tomasone JR, Loblaw A, Petrella T et al (2017) Exercise for people with cancer: a clinical practice guideline. Curr Oncol 24(1):40–46
pubmed: 28270724 pmcid: 5330628 doi: 10.3747/co.24.3376
Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS et al (2019) Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc 51(11):2375–2390
pubmed: 31626055 pmcid: 8576825 doi: 10.1249/MSS.0000000000002116
Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM et al (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42(7):1409–1426
pubmed: 20559064 doi: 10.1249/MSS.0b013e3181e0c112
Loughney LA, West MA, Kemp GJ, Grocott MP, Jack S (2018) Exercise interventions for people undergoing multimodal cancer treatment that includes surgery. Cochrane Database Syst Rev 12:CD012280
pubmed: 30536366
Thorsen L, Haugnes HS, Fossa SD, Brydoy M, Tandstad T, Wisloff T et al (2020) Thromboembolic events after high-intensity training during cisplatin-based chemotherapy for testicular cancer: case reports and review of the literature. Int J Cancer 147(11):3189–3198
pubmed: 32525564 doi: 10.1002/ijc.33151
Petrella AR, Sabiston CM, O’Rourke RH, Santa Mina D, Hamilton RJ, Matthew AG (2022) Process evaluation of a sport-based supportive care intervention for testicular cancer survivors: a mixed methods study. Cancers 14(11):2800
pubmed: 35681779 pmcid: 9179291 doi: 10.3390/cancers14112800
Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36(5):936–942
pubmed: 7137077 doi: 10.1093/ajcn/36.5.936
Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B, Bergeron J et al (2001) Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med 161(22):2685–2692
pubmed: 11732933 doi: 10.1001/archinte.161.22.2685
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary. Crit Pathw Cardiol 4(4):198–203
pubmed: 18340209 doi: 10.1097/00132577-200512000-00018
Florindo AA, Latorre MD (2003) Validation and reliability of the Baecke questionnaire for the evaluation of habitual physical activity in adult men. Rev Bras Med Esporte 9:129–135
doi: 10.1590/S1517-86922003000300002
Silva FG, Oliveira CB, Hisamatsu TM, Negrão Filho RF, Rodrigues CRD, Franco MR et al (2020) Critical evaluation of physical activity questionnaires translated to Brazilian-Portuguese: a systematic review on cross-cultural adaptation and measurements properties. Braz J Phys Ther 24(3):187–218
pubmed: 31085135 doi: 10.1016/j.bjpt.2019.04.002
Tebar WR, Ritti-Dias RM, Fernandes RA, Damato TM, Barros MV, Mota J et al (2022) Validity and reliability of the Baecke questionnaire against accelerometer-measured physical activity in community dwelling adults according to educational level. PLoS One 17(8):e0270265
pubmed: 35969609 pmcid: 9377570 doi: 10.1371/journal.pone.0270265
Sloan JA, Cheville AL, Liu H, Novotny PJ, Wampfler JA, Garces YI et al (2016) Impact of self-reported physical activity and health promotion behaviors on lung cancer survivorship. Health Qual Life Outcomes 14(1):1–14
doi: 10.1186/s12955-016-0461-3
Ribeiro FE, Tebar WR, Ferrari G, Palma MR, Fregonesi CE, Caldeira DT et al (2023) Comparison of quality of life in breast cancer survivors with and without persistent depressive symptoms: a 12-month follow-up study. Int J Environ Res Public Health 20(4):3663
pubmed: 36834358 pmcid: 9966205 doi: 10.3390/ijerph20043663
Kurdiova T, Balaz M, Vician M, Maderova D, Vlcek M, Valkovic L et al (2014) Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies. J Physiol 592(5):1091–1107
pubmed: 24297848 pmcid: 3948565 doi: 10.1113/jphysiol.2013.264655
Pedersen BK, Saltin B (2006) Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 16(Suppl 1):3–63
pubmed: 16451303 doi: 10.1111/j.1600-0838.2006.00520.x
Adams SC, DeLorey DS, Davenport MH, Stickland MK, Fairey AS, North S et al (2017) Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: a phase 2 randomized controlled trial. Cancer 123(20):4057–4065
pubmed: 28708930 doi: 10.1002/cncr.30859
van Roekel EH, Bours MJL, van Delden L, Breukink SO, Aquarius M, Keulen ETP et al (2021) Longitudinal associations of physical activity with plasma metabolites among colorectal cancer survivors up to 2 years after treatment. Sci Rep 11(1):13738
pubmed: 34215757 pmcid: 8253824 doi: 10.1038/s41598-021-92279-9
Chen L, Kong X, Wang Z, Wang X, Fang Y, Wang J (2020) Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy. J Cell Mol Med 24(5):2993–3021
pubmed: 31989747 pmcid: 7077539 doi: 10.1111/jcmm.14934
Aziz MH, Sideras K, Aziz NA, Mauff K, Haen R, Roos D et al (2019) The systemic-immune-inflammation index independently predicts survival and recurrence in resectable pancreatic cancer and its prognostic value depends on bilirubin levels: a retrospective multicenter cohort study. Ann Surg 270(1):139–146
pubmed: 29334554 doi: 10.1097/SLA.0000000000002660
Chen JH, Zhai ET, Yuan YJ, Wu KM, Xu JB, Peng JJ et al (2017) Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol 23(34):6261–6272
pubmed: 28974892 pmcid: 5603492 doi: 10.3748/wjg.v23.i34.6261
Li H, Wu X, Bai Y, Wei W, Li G, Fu M et al (2021) Physical activity attenuates the associations of systemic immune-inflammation index with total and cause-specific mortality among middle-aged and older populations. Sci Rep 11(1):12532
pubmed: 34131164 pmcid: 8206152 doi: 10.1038/s41598-021-91324-x
Booth FW, Roberts CK, Laye MJ (2012) Lack of exercise is a major cause of chronic diseases. Compr Physiol 2(2):1143–1211
pubmed: 23798298 pmcid: 4241367 doi: 10.1002/cphy.c110025
Ng HS, Roder D, Koczwara B, Vitry A (2018) Comorbidity, physical and mental health among cancer patients and survivors: an Australian population-based study. Asia-Pac J Clin Oncol 14(2):e181–ee92
pubmed: 28371441 doi: 10.1111/ajco.12677
Haugnes HS, Aass N, Fosså SD, Dahl O, Klepp O, Wist EA et al (2007) Components of the metabolic syndrome in long-term survivors of testicular cancer. Ann Oncol 18(2):241–248
pubmed: 17060482 doi: 10.1093/annonc/mdl372
Feldman DR, Ardeshir-Rouhani-Fard S, Monahan P, Sesso HD, Fung C, Williams AM et al (2018) Predicting cardiovascular disease among testicular cancer survivors after modern cisplatin-based chemotherapy: application of the Framingham Risk Score. Clin Genitourin Cancer 16(4):e761–e7e9
pubmed: 29534941 pmcid: 6063791 doi: 10.1016/j.clgc.2018.01.011
Fung C, Sesso HD, Williams AM, Kerns SL, Monahan P, Abu Zaid M et al (2017) Multi-institutional assessment of adverse health outcomes among North American testicular cancer survivors after modern cisplatin-based chemotherapy. J Clin Oncol 35(11):1211–1222
pubmed: 28240972 pmcid: 5455601 doi: 10.1200/JCO.2016.70.3108

Auteurs

Ali Amiri (A)

Department of Metabolic Disease Research & Center of Physical Activity Research, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.

Patrik Krumpolec (P)

Department of Metabolic Disease Research & Center of Physical Activity Research, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.

Michal Mego (M)

2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.

Barbara Ukropcová (B)

Department of Metabolic Disease Research & Center of Physical Activity Research, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.

Michal Chovanec (M)

2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.

Jozef Ukropec (J)

Department of Metabolic Disease Research & Center of Physical Activity Research, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia. jozef.ukropec@savba.sk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH